medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2009, Number 2

<< Back Next >>

Ann Hepatol 2009; 8 (2)

Hepatic encephalopathy, ammonia, glutamate, glutamine and oxidative stress

Lemberg A, Fernández MA

Language: English
References: 61
Page: 95-102
PDF size: 77.31 Kb.


Text Extraction

This review addresses recent and not so recent works that emphasize on the mechanisms by which liver damage can induce encephalopathy. Hepatic encephalopathy constitutes an intriguing complication in severe liver acute and chronic disease, whose pathophysiology is still not completely understood. In this pathology, alterations in normal brain function are associated with morphological and functional impairments of astrocytes and neurons. A wide spectrum of psychoneurological symptoms has been described and the anatomical substratum is usually associated with brain edema and intracranial hypertension, as well as with changes in the function of brain cells. An increase in blood ammonia, toxic to the brain, depends on the activity of the enzyme glutamine synthetase, the glutamine/glutamate cycle and the brain capacity to eliminate toxic substances. When the concentration of the excitotoxic neurotransmitter glutamate is increased, it acts as a toxic agent, especially when its specific transporters are altered and its uptake is decreased. Glutamine has also been recently considered a toxic substance when its concentration is high, and consequently contributes to brain edema. Finally, the formation of reactive oxygen species, basically produced by mitochondria, influence with their toxic action on membrane lipids, proteins and DNA. In conclusion we suggest that at least these four elements are involved directly in the mechanism of hepatic encephalopathy.


REFERENCES

  1. Blendis L. Hepatic encephalopathy forward to the past. Gastroenterology 2006; 130: 2239-2240.

  2. Abou-Assi S, Vlahcevic ZR. Hepatic encephalopathy. Metabolic consequence of cirrhosis often is reversible. Postgrad Med 2001; 109: 52-60, 63.

  3. Kulisevsky J, Pujol J, Balanzo J, Junque C, Deus J, Capdevilla A, et al. Pallidal hyperintensity on magnetic resonance imaging in cirrhotic patients: clinical correlations. Hepatology 1992; 16: 1382-1388.

  4. Mans AM, DeJoseph MR, Hawkins RA. Metabolic abnormalities and grade of encephalopathy in acute hepatic failure. J Neurochem 1994; 63: 1829-1838.

  5. Lemberg A, Werber DH, Gilardoni A, Magrino HJ. Presence of serum creatine kinase isoenzymes in liver failure with cerebral involvement. Clin Chim Acta 1977; 80: 385-390.

  6. Szerb JC, Butterworth RF. Effect of ammonium ions on synaptic transmission in the mammalian central nervous system. Prog Neurobiol 1992; 39: 135-153.

  7. Norenberg MD, Martinez-Hernandez A. Fine structural localization of glutamine synthetase in astrocytes of rat brain. Brain Res 1979; 161: 303-310.

  8. Norenberg MD. The role of astrocytes in hepatic encephalopathy. Neurochem Pathol 1987; 6: 13-33.

  9. Cummins JT, Hamberger A, Nystrom B. Effects of low ammonia levels on NAD [P]H levels and glutamate secretion during calcium-dependent depolarization of CNS slices. J Neurosci Res 1981; 6: 217-224.

  10. Lai JC, Cooper AJ. Brain alpha-ketoglutarate dehydrogenase complex: kinetic properties, regional distribution, and effects of inhibitors. J Neurochem 1986; 47: 1376-1386.

  11. Vaquero J, Butterworth RF. Mechanisms of brain edema in acute liver failure and impact of novel therapeutic interventions. Neurol Res 2008; 29: 683-690.

  12. Sinke AP, Jayakumar AR, Panickar KS, Moriyama M, Reddy PV, Norenberg MD. NFkappaB in the mechanism of ammonia-induced astrocyte swelling in culture. J Neurochem. 2008 Sep; 106(6):2302-11.

  13. Gorg B, Qvartskhava N, Keitel V, Bidmon HJ, Selbach O, Schliess F, et al. Ammonia induces RNA oxidation in cultured astrocytes and brain in vivo. Hepatology 2008; 48: 567-579.

  14. Bai G, Rama Rao KV, Murthy CR, Panickar KS, Jayakumar AR, Norenberg MD. Ammonia induces the mitochondrial permeability transition in primary cultures of rat astrocytes. J Neurosci Res 2001; 66: 981-991.

  15. Schmidt W, Wolf G, Grungreiff K, Meier M, Reum T. Hepatic encephalopathy influences high-affinity uptake of transmitter glutamate and aspartate into the hippocampal formation. Metab Brain Dis 1990; 5: 19-31.

  16. Desjardins P, Rao KV, Michalak A, Rose C, Butterworth RF. Effect of portacaval anastomosis on glutamine synthetase protein and gene expression in brain, liver and skeletal muscle. Metab Brain Dis 1999; 14: 273-280.

  17. Suarez I, Bodega G, Fernandez B. Modulation of glutamate transporters [GLAST, GLT-1 and EAAC1] in the rat cerebellum following portocaval anastomosis. Brain Res 2000; 859: 293-302.

  18. Bender AS, Norenberg MD. Effects of ammonia on L-glutamate uptake in cultured astrocytes. Neurochem Res 1996; 21: 567-573.

  19. Chan H, Butterworth RF. Evidence for an astrocytic glutamate transporter deficit in hepatic encephalopathy. Neurochem Res 1999; 24: 1397-1401.

  20. Tofteng F, Jorgensen L, Hansen BA, Ott P, Kondrup J, Larsen FS. Cerebral microdialysis in patients with fulminant hepatic failure. Hepatology 2002; 36: 1333-1340.

  21. Tofteng F, Hauerberg J, Hansen BA, Pedersen CB, Jorgensen L, Larsen FS. Persistent arterial hyperammonemia increases the concentration of glutamine and alanine in the brain and correlates with intracranial pressure in patients with fulminant hepatic failure. J Cereb Blood Flow Metab 2006; 26: 21-27.

  22. Hamberger A, Hedquist B, Lundborg H, Nystrom B. Hippocampal glutamate release after porta cava anastomosis: reduced sensitivity to ammonia inhibition. J Neurosci Res 1980; 5: 313-322.

  23. McArdle P, Penning DH, Dexter F, Reynolds JD. Flumazenil does not affect the increase in rat hippocampal extracellular glutamate concentration produced during thioacetamide-induced hepatic encephalopathy. Metab Brain Dis 1996; 11: 329-342.

  24. de Knegt RJ, Schalm SW, van der Rijt CC, Fekkes D, Dalm E, Hekking-Weyma I. Extracellular brain glutamate during acute liver failure and during acute hyperammonemia simulating acute liver failure: an experimental study based on in vivo brain dialysis. J Hepatol 1994; 20: 19-26.

  25. Suzuki K, Matsuo N, Moriguchi T, Takeyama N, Kitazawa Y, Tanaka T. Changes in brain ECF amino acids in rats with experimentally induced hyperammonemia. Metab Brain Dis 1992; 7: 63-75.

  26. Rose C, Michalak A, Pannunzio M, Chatauret N, Rambaldi A, Butterworth RF. Mild hypothermia delays the onset of coma and prevents brain edema and extracellular brain glutamate accumulation in rats with acute liver failure. Hepatology 2000; 31: 872-877.

  27. Rose C, Kresse W, Kettenmann H. Acute insult of ammonia leads to calcium-dependent glutamate release from cultured astrocytes, an effect of pH. J Biol Chem 2005; 280: 20937-20944.

  28. Felipo V. Contribution of altered signal transduction associated to glutamate receptors in brain to the neurological alterations of hepatic encephalopathy. World J Gastroenterol 2006; 12: 7737-7743.

  29. Llansola M, Rodrigo R, Monfort P, Montoliu C, Kosenko E, Cauli O, et al. NMDA receptors in hyperammonemia and hepatic encephalopathy. Metab Brain Dis 2007; 22: 321-335.

  30. Nicholls DG. Mitochondrial dysfunction and glutamate excitotoxicity studied in primary neuronal cultures. Curr Mol Med 2004; 4: 149-177.

  31. Perazzo JC, Lores AS, Fernández MA, Lago N, Lemberg A. Prehepatic portal hypertension and mitochondrial dysfunction in brain hippocampus. In: D.Haussinger GKaFS, editor. Hepatic Encephalopathy and Nitrogen Metabolism 2006: 194-201.

  32. Hertz L, Murthy CR, Lai JC, Fitzpatrick SM, Cooper AJ. Some metabolic effects of ammonia on astrocytes and neurons in primary cultures. Neurochem Pathol 1987; 6: 97-129.

  33. Kala G, Hertz L. Ammonia effects on pyruvate/lactate production in astrocytes—interaction with glutamate. Neurochem Int 2005; 47: 4-12.

  34. Gruetter R, Novotny EJ, Boulware SD, Mason GF, Rothman DL, Shulman GI, et al. Localized 13C NMR spectroscopy in the human brain of amino acid labeling from D-[1-13C]glucose. J Neurochem 1994; 63: 1377-1385.

  35. Smith QR. Transport of glutamate and other amino acids at the blood-brain barrier. J Nutr 2000; 130: 1016S-22S.

  36. Scorticati C, Prestifilippo JP, Eizayaga FX, Castro JL, Romay S, Fernandez MA, et al. Hyperammonemia, brain edema and blood-brain barrier alterations in prehepatic portal hypertensive rats and paracetamol intoxication. World J Gastroenterol 2004; 10: 1321-1324.

  37. Eizayaga F, Scorticati C, Prestifilippo JP, Romay S, Fernandez MA, Castro JL, et al. Altered blood-brain barrier permeability in rats with prehepatic portal hypertension turns to normal when portal pressure is lowered. World J Gastroenterol 2006; 12: 1367-1372.

  38. Albrecht J, Dolinska M. Glutamine as a pathogenic factor in hepatic encephalopathy. J Neurosci Res 2001; 65: 1-5.

  39. Norenberg MD. Astrocytic-ammonia interactions in hepatic encephalopathy. Semin Liver Dis 1996; 16: 245-253.

  40. Norenberg MD, Baker L, Norenberg LO, Blicharska J, Bruce-Gregorios JH, Neary JT. Ammonia-induced astrocyte swelling in primary culture. Neurochem Res 1991; 16: 833-836.

  41. Master S, Gottstein J, Blei AT. Cerebral blood flow and the development of ammonia-induced brain edema in rats after portacaval anastomosis. Hepatology 1999; 30: 876-880.

  42. Blei AT, Olafsson S, Therrien G, Butterworth RF. Ammonia-induced brain edema and intracranial hypertension in rats after portacaval anastomosis. Hepatology 1994; 19: 1437-1444.

  43. Hawkins RA, Jessy J, Mans AM, De Joseph MR. Effect of reducing brain glutamine synthesis on metabolic symptoms of hepatic encephalopathy. J Neurochem 1993; 60: 1000-1006.

  44. Albrecht J, Dolinska M, Hilgier W, Lipkowski AW, Nowacki J. Modulation of glutamine uptake and phosphate-activated glutaminase activity in rat brain mitochondria by amino acids and their synthetic analogues. Neurochem Int 2000; 36: 341-347.

  45. Shawcross DL, Balata S, Olde Damink SW, Hayes PC, Wardlaw J, Marshall I, et al. Low myo-inositol and high glutamine levels in brain are associated with neuropsychological deterioration after induced hyperammonemia. Am J Physiol Gastrointest Liver Physiol 2004; 287: G503-G509.

  46. Albrecht J, Norenberg MD. Glutamine: a Trojan horse in ammonia neurotoxicity. Hepatology 2006; 44: 788-794.

  47. Detry O, De Roover A, Honore P, Meurisse M. Brain edema and intracranial hypertension in fulminant hepatic failure: pathophysiology and management. World J Gastroenterol 2006; 12: 7405-7412.

  48. Dejong CH, Deutz NE, Soeters PB. Ammonia and glutamine metabolism during liver insufficiency: the role of kidney and brain in interorgan nitrogen exchange. Scand J Gastroenterol Suppl 1996; 218: 61-77.

  49. Derouiche A, Frotscher M. Astroglial processes around identified glutamatergic synapses contain glutamine synthetase: evidence for transmitter degradation. Brain Res 1991; 552: 346-350.

  50. Zwingmann C, Chatauret N, Leibfritz D, Butterworth RF. Selective increase of brain lactate synthesis in experimental acute liver failure: results of a [H-C] nuclear magnetic resonance study. Hepatology 2003; 37: 420-428.

  51. Murthy CR, Rama Rao KV, Bai G, Norenberg MD. Ammonia-induced production of free radicals in primary cultures of rat astrocytes. J Neurosci Res 2001; 66: 282-288.

  52. Song G, Dhodda VK, Blei AT, Dempsey RJ, Rao VL. GeneChip analysis shows altered mRNA expression of transcripts of neurotransmitter and signal transduction pathways in the cerebral cortex of portacaval shunted rats. J Neurosci Res 2002; 68: 730-737.

  53. Blanc EM, Keller JN, Fernandez S, Mattson MP. 4-hydroxynonenal, a lipid peroxidation product, impairs glutamate transport in cortical astrocytes. Glia 1998; 22: 149-160.

  54. Kaplowitz N, Tsukamoto H. Oxidative stress and liver disease. Prog Liver Dis 1996; 14: 131-159.

  55. Tirosh O, Sen CK, Roy S, Packer L. Cellular and mitochondrial changes in glutamate-induced HT4 neuronal cell death. Neuroscience 2000; 97: 531-541.

  56. Kosenko E, Kaminsky Y, Kaminsky A, Valencia M, Lee L, Hermenegildo C, et al. Superoxide production and antioxidant enzymes in ammonia intoxication in rats. Free Radic Res 1997; 27: 637-644.

  57. Norenberg MD. Oxidative and nitrosative stress in ammonia neurotoxicity. Hepatology 2003; 37: 245-248.

  58. Lemberg A, Schreier L, Romay S, Fernandez MA, Rosello D, Gonzales S, et al. Involvement of serum apolipoprotein AI and B100 and lecithin cholesterol acyl transferase in alcoholic cirrhotics. Ann Hepatol 2007; 6: 227-232.

  59. Bates TE, Williams SR, Kauppinen RA, Gadian DG. Observation of cerebral metabolites in an animal model of acute liver failure in vivo: a 1H and 31P nuclear magnetic resonance study. J Neurochem 1989; 53: 102-110.

  60. Layrargues GP, Shapcott D, Spahr L, Butterworth RF. Accumulation of manganese and copper in pallidum of cirrhotic patients: role in the pathogenesis of hepatic encephalopathy? Metab Brain Dis 1995; 10: 353-356.

  61. Rose C, Butterworth RF, Zayed J, Normandin L, Todd K, Michalak A, et al. Manganese deposition in basal ganglia structures results from both portal-systemic shunting and liver dysfunction. Gastroenterology 1999; 117: 640-644.




2020     |     www.medigraphic.com